» Articles » PMID: 38899879

Recognition of by Toll-like Receptor 9 is Altered During Persistence

Overview
Journal Infect Immun
Date 2024 Jun 20
PMID 38899879
Authors
Affiliations
Soon will be listed here.
Abstract

Toll-like receptor 9 (TLR9) is an innate immune receptor that localizes to endosomes in antigen presenting cells and recognizes single stranded unmethylated CpG sites on bacterial genomic DNA (gDNA). Previous bioinformatic studies have demonstrated that the genome of the human pathogen contains TLR9 stimulatory motifs, and correlative studies have implied a link between human TLR9 (hTLR9) genotype variants and susceptibility to infection. Here, we present our evaluation of the stimulatory potential of gDNA and its recognition by hTLR9- and murine TLR9 (mTLR9)-expressing cells. Utilizing reporter cell lines, we demonstrate that purified gDNA from can stimulate hTLR9 signaling, albeit at lower levels than gDNA prepared from other Gram-negative bacteria. Interestingly, we found that while is capable of signaling through hTLR9 and mTLR9 during live infections in HEK293 reporter cell lines, signaling only occurs at later developmental time points. Chlamydia-specific induction of hTLR9 is blocked when protein synthesis is inhibited prior to the RB-to-EB conversion, exacerbated by the inhibition of lipooligosaccharide biosynthesis, and is significantly altered during the induction of aberrance/persistence. Our observations support the hypothesis that chlamydial gDNA is released during the conversion between the pathogen's replicative and infectious forms and during treatment with antibiotics targeting peptidoglycan assembly. Given that inclusions do not co-localize with TLR9-containing vacuoles in the pro-monocytic cell line U937, our findings also hint that chlamydial gDNA is capable of egress from the inclusion, and traffics to TLR9-containing vacuoles via an as yet unknown pathway.

References
1.
Darville T, ONeill J, Andrews Jr C, Nagarajan U, Stahl L, Ojcius D . Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol. 2003; 171(11):6187-97. DOI: 10.4049/jimmunol.171.11.6187. View

2.
Lambden P, Pickett M, Clarke I . The effect of penicillin on Chlamydia trachomatis DNA replication. Microbiology (Reading). 2006; 152(Pt 9):2573-2578. DOI: 10.1099/mic.0.29032-0. View

3.
Heine H, Gronow S, Zamyatina A, Kosma P, Brade H . Investigation on the agonistic and antagonistic biological activities of synthetic Chlamydia lipid A and its use in in vitro enzymatic assays. J Endotoxin Res. 2007; 13(2):126-32. DOI: 10.1177/0968051907079122. View

4.
Lyons J, Ito Jr J, Pena A, Morre S . Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum. J Clin Pathol. 2005; 58(4):397-401. PMC: 1770636. DOI: 10.1136/jcp.2004.021543. View

5.
Heinzen R, Scidmore M, Rockey D, Hackstadt T . Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect Immun. 1996; 64(3):796-809. PMC: 173840. DOI: 10.1128/iai.64.3.796-809.1996. View